Skip to main content
. 2012 Aug 16;10:165. doi: 10.1186/1479-5876-10-165

Figure 1 .

Figure 1

Plasma protein concentrations in individual patients during treatment with sunitinib. (A) sKIT. (B) VEGF-A. (C) sVEGFR-2. (D) sVEGFR-3. sKIT, soluble KIT; sVEGFR, soluble vascular endothelial growth factor receptor; VEGF, vascular endothelial growth factor.